[go: up one dir, main page]

WO2007047501A3 - Outer membrane vesicles: novel vaccine for gram-negative biothreat agents - Google Patents

Outer membrane vesicles: novel vaccine for gram-negative biothreat agents Download PDF

Info

Publication number
WO2007047501A3
WO2007047501A3 PCT/US2006/040203 US2006040203W WO2007047501A3 WO 2007047501 A3 WO2007047501 A3 WO 2007047501A3 US 2006040203 W US2006040203 W US 2006040203W WO 2007047501 A3 WO2007047501 A3 WO 2007047501A3
Authority
WO
WIPO (PCT)
Prior art keywords
gram
outer membrane
negative
membrane vesicles
novel vaccine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2006/040203
Other languages
French (fr)
Other versions
WO2007047501A2 (en
Inventor
Hoek Monique L Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
George Mason University
Original Assignee
George Mason University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by George Mason University filed Critical George Mason University
Publication of WO2007047501A2 publication Critical patent/WO2007047501A2/en
Publication of WO2007047501A3 publication Critical patent/WO2007047501A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0208—Specific bacteria not otherwise provided for
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/543—Mucosal route intranasal
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

An immunogenic composition for the immunization of an individual comprising outer membrane vesicles of Gram-negative bacteria, Francisella or Yersinia spp.
PCT/US2006/040203 2005-10-14 2006-10-16 Outer membrane vesicles: novel vaccine for gram-negative biothreat agents Ceased WO2007047501A2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72623805P 2005-10-14 2005-10-14
US60/726,238 2005-10-14

Publications (2)

Publication Number Publication Date
WO2007047501A2 WO2007047501A2 (en) 2007-04-26
WO2007047501A3 true WO2007047501A3 (en) 2007-10-04

Family

ID=37963134

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2006/040203 Ceased WO2007047501A2 (en) 2005-10-14 2006-10-16 Outer membrane vesicles: novel vaccine for gram-negative biothreat agents

Country Status (1)

Country Link
WO (1) WO2007047501A2 (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103079592B (en) * 2010-07-01 2015-10-21 浦项工科大学校产学协力团 Methods of treating and diagnosing cancer using microvesicles derived from cells
EP3068426B1 (en) * 2013-11-13 2020-02-12 University Of Oslo Outer membrane vesicles and uses thereof
US20180177725A1 (en) * 2015-09-10 2018-06-28 Washington State University Cell membrane-formed nanoscale vesicles and methods of using thereof
KR20170104024A (en) * 2016-03-03 2017-09-14 주식회사 엠디헬스케어 Nanovesicles derived from Helicobacter pylori and Use thereof
CN112410239B (en) * 2019-08-22 2023-03-24 四川大学 Bacterial membrane vesicle and preparation method and application thereof
CN113144182B (en) * 2021-04-22 2023-03-10 成都欧林生物科技股份有限公司 Helicobacter pylori oral sustained-release vaccine and preparation and application thereof

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013689A1 (en) * 1995-08-04 2004-01-22 University Of Guelph Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US20040265330A1 (en) * 1999-01-22 2004-12-30 Smithkline Beecham Biologicals S.A. Novel compounds

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040013689A1 (en) * 1995-08-04 2004-01-22 University Of Guelph Novel vaccines and pharmaceutical compositions using membrane vesicles of microorganisms, and methods for preparing same
US20040265330A1 (en) * 1999-01-22 2004-12-30 Smithkline Beecham Biologicals S.A. Novel compounds

Also Published As

Publication number Publication date
WO2007047501A2 (en) 2007-04-26

Similar Documents

Publication Publication Date Title
GB0419627D0 (en) Immunogenic bacterial vesicles with outer membrane proteins
WO2008100805A3 (en) Anti-robo4 antibodies and uses therefor
WO2007049155A3 (en) Compositions comprising yersinia pestis antigens
WO2007133290A3 (en) Anti-ox40l antibodies and methods using same
WO2007076260A3 (en) Farnesoid x receptor agonists
EP2433647A3 (en) GNA1870-based vesicle vaccines for broad spectrum protection against diseases caused by Neisseria meningitidis
WO2008060705A3 (en) Anti-dll4 antibodies and methods using same
EP2535058A3 (en) Stabilization of vaccines by lyophilization
WO2004062597A3 (en) Compositions, methods and kits for enhancing the immunogenicity of a bacterial vaccine vector
WO2007120334A8 (en) Methods and compositions for targeting polyubiquitin
WO2009009759A3 (en) Yersinia pestis antigens, vaccine compositions, and related methods
WO2007130697A3 (en) Anti-ephb4 antibodies and methods using same
WO2007021672A3 (en) Vaccination against dengue virus infection
ATE529123T1 (en) SYNTHETIC GLYCOLIPOPEPTIDES AS VACCINES
WO2006091722A3 (en) Alkyl-glycoside enhanced vaccination
WO2007127506A8 (en) Anti-ephrinb2 antibodies and methods using same
WO2006031926A3 (en) Methods for the isolation and expansion of cord blood derived t regulatory cells
AP2005003375A0 (en) Antibacterial indolone oxazolidinones, intermediates for their preparation and pharmaceutical compositions containing them.
MX2012004622A (en) Adjuvant for vaccines, vaccines that comprise said adjuvant and uses thereof.
WO2007047501A3 (en) Outer membrane vesicles: novel vaccine for gram-negative biothreat agents
AU2003255275A1 (en) Improved anthrax vaccines and delivery methods
WO2006091848A3 (en) Isolated bis-linezolid, preparation thereof, and its use as a reference standard
WO2006031787A3 (en) Low-obscuration image transmitting particulate ocular therapeutic formulations
WO2003006665A8 (en) Lawsonia intracellularis
WO2008107771A3 (en) 2',3'-di-o-acyl-5-fluoronucleosides

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 06825956

Country of ref document: EP

Kind code of ref document: A2